Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity.

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502

Insulin resistance and cardiovascular disease

Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,372

Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

Lewis, G. F., Carpentier, A. C., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,370

Hypertriglyceridemia as a Result of Human apo CII Gene Expression in Transgenic Mice

Ito, Y., Azrolan, N., O'Connell, A., Walsh, A., & Breslow, J. L. (1990) · Science · doi:10.1126/science.2167514 · Cited by 539

Role of apoCs in lipoprotein metabolism: functional differences between apoC1, apoC2, and apoC3

Jong, M. C., Hofker, M. H., & Havekes, L. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.472 · Cited by 539

Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein

Brown, W. V., & Baginsky, M. L. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(72)80149-9 · Cited by 493

Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.

Aalto‐Setälä, K., Fisher, E. A. A., Chen, X., Chajek‐Shaul, T., Hayek, T., Zechner, R., Walsh, A., Ramakrishnan, R., Ginsberg, H. N., & Breslow, J. L. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116066 · Cited by 453

Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoprotein lipase from different sources

Havel, R. J., Fielding, C. J., Olivecrona, T., Shore, V. G., Fielding, P. E., & Egelrud, T. (1973) · Biochemistry · doi:10.1021/bi00733a026 · Cited by 332

Effects of Acute Hyperinsulinemia on VLDL Triglyceride and VLDL ApoB Production in Normal Weight and Obese Individuals

Lewis, G. F., Uffelman, K. D., Szeto, L., & Steiner, G. A. (1993) · Diabetes · doi:10.2337/diab.42.6.833 · Cited by 323

Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.

Windler, E. E. T., & Havel, R. J. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34342-x · Cited by 314

Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma

Nguyen, M. N., Chan, D. C., Dwyer, K. P., Bolitho, P., Watts, G. F., & Barrett, P. H. R. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600018-jlr200 · Cited by 23

Islet inflammation in plain sight

Abdulreda, M. H., & Berggren, P. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12160 · Cited by 23

Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status

Lamon‐Fava, S., Herrington, D. M., Horvath, K. V., Schaefer, E. J., & Asztalos, B. F. (2010) · Metabolism · doi:10.1016/j.metabol.2010.05.012 · Cited by 22

Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size

van Schalkwijk, D. B., de Graaf, A. A., van Ommen, B., van Bochove, K., Rensen, P. C. N., Havekes, L. M., van de Pas, N. C. A., Hoefsloot, H. C. J., van der Greef, J., & Freidig, A. P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800354-jlr200 · Cited by 21

The Disruption of Liver Metabolic Circadian Rhythms by a Cafeteria Diet Is Sex-Dependent in Fischer 344 Rats

Palacios, H. H., Martín‐González, M. Z., Suárez, M., Aragonès, G., Muguerza, B., Rodriguez, M. A., & Bladé, C. (2020) · Nutrients · doi:10.3390/nu12041085 · Cited by 23

Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men

Wong, A. T. Y., Chan, D. C., Ooi, E. M. M., Ng, T. W., Watts, G. F., & Barrett, P. H. R. (2013) · Clinical Science · doi:10.1042/cs20120587 · Cited by 20

APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice

Cheng, X., Yamauchi, J., Lee, S., Zhang, T., Gong, Z., Muzumdar, R. H., Qu, S., & Dong, H. H. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.765917 · Cited by 21

Apolipoprotein CIII and diabetes. Is there a link?

Christopoulou, E. C., Tsimihodimos, V., Filippatos, T. D., & Elisaf, M. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3118 · Cited by 21

Cannabis effects on lipoproteins

Lazarte, J., & Hegele, R. A. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000575 · Cited by 18

Macromolecular Interactions of Lipoprotein Lipase (LPL)

Wheless, A., Gunn, K. H., & Neher, S. B. (2024) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-58843-3_8 · Cited by 19

In vivo postprandial lipid partitioning in liver and skeletal muscle in prediabetic and diabetic rats

Jonkers, R. A. M., van Loon, L. J. C., Nicolay, K., & Prompers, J. J. (2012) · Diabetologia · doi:10.1007/s00125-012-2792-x · Cited by 17

Association of complete blood cell counts with metabolic syndrome in an elderly population

Li, P., Chen, J.-S., Chang, J., Chang, H.-W., Wu, C., Chuang, T.-J., Huang, C.-L., Pei, D., Hsieh, C., & Chen, Y. (2016) · BMC Geriatrics · doi:10.1186/s12877-016-0182-9 · Cited by 17

Impact of bariatric surgery on apolipoprotein C-III levels and lipoprotein distribution in obese human subjects

Maraninchi, M., Padilla, N., Béliard, S., Berthet, B., Nogueira, J. P., Dupont-Roussel, J., Mancini, J., Corroller, A. B., Dubois, N., Grangeot, R., et al. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.02.012 · Cited by 16

Clinical research Small dense LDL cholesterol and apolipoproteins C-II and C-III in non-diabetic obese subjects with metabolic syndrome

Filippatos, T. D., Tsimihodimos, V., Kostapanos, M. S., Kostara, C. E., Bairaktari, E. T., Kiortsis, D. N., Tselepis, A. D., & Elisaf, M. (2008) · Cited by 14

Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice

Liu, Y., Cheng, X., Zhang, T., Lee, S., Yamauchi, J., Xiao, X., Gittes, G. K., Qu, S., Jiang, C., & Dong, H. H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.707885 · Cited by 14

Potential Impact of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Pathophysiology in Type 2 Diabetes Mellitus

Davidson, M. H. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.05.2756 · Cited by 13

Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese men

Chan, D. C., Watts, G. F., Ooi, E. M. M., Chan, D. T., Wong, A. T. Y., & Barrett, P. H. R. (2011) · Metabolism · doi:10.1016/j.metabol.2011.03.003 · Cited by 13

Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins

Wang, L., Sacks, F. M., Furtado, J. D., Ricks, M., Courville, A. B., & Sumner, A. E. (2014) · Nutrition & Metabolism · doi:10.1186/1743-7075-11-56 · Cited by 11

Closing the gaps in patient management of dyslipidemia: stepping into cardiovascular precision diagnostics with apolipoprotein profiling

Reijnders, E., van der Laarse, A., Ruhaak, L. R., & Cobbaert, C. M. (2024) · Clinical Proteomics · doi:10.1186/s12014-024-09465-w · Cited by 10

Therapeutic inhibition of apoC-III for the treatment of hypertriglyceridemia

Bell, T. A., Graham, M. J., Baker, B. F., & Crooke, R. M. (2015) · Clinical Lipidology · doi:10.2217/clp.15.7 · Cited by 9

Kinetics of plasma apolipoprotein C-III as a determinant of diet-induced changes in plasma triglyceride levels

Desroches, S., Ruel, I. L., Deshaies, Y., Paradis, M.-E., Archer, W. R., Couture, P., Bergeron, N., & Lamarche, B. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602673 · Cited by 9

Dyslipidemia, inflammation and dialysis outcomes: what we know now

Krane, V., Drechsler, C., & Wanner, C. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000247501.41420.dd · Cited by 8

Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ1-HDL, α-HDL, and triglyceride-rich lipoproteins

Chétiveaux, M., Croyal, M., Ouguerram, K., Fall, F., Flet, L., Zaïr, Y., Nobécourt, E., & Krempf, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-72323-w · Cited by 7

Is APOC3 the driver of cardiovascular disease in people with type I diabetes mellitus?

Ginsberg, H. N., & Reyes‐Soffer, G. (2019) · Journal of Clinical Investigation · doi:10.1172/jci131333 · Cited by 7

FoxO6-mediated ApoC3 upregulation promotes hepatic steatosis and hyperlipidemia in aged rats fed a high-fat diet

Kim, D. H., Lee, S., Noh, S. G., Lee, J., & Chung, H. Y. (2024) · Aging · doi:10.18632/aging.205610 · Cited by 6

Liver fat response to two days fasting and two days isocaloric high-carbohydrate refeeding in lean and obese women

Šedivý, P., Dusilová, T., Šetinová, B., Pajuelo, D., Hájek, M., Rossmeislová, L., Šiklová, M., Šrámková, V., Krauzová, E., Gojda, J., et al. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.09.030 · Cited by 5

The antagonic behavior of GPIHBP1 between EAT and circulation does not reflect lipolytic enzymes levels in the tissue and serum from coronary patients

Barchuk, M., Nagasawa, T., Murakami, M., Lopez, G. I., Baldi, J., Miksztowicz, V., Rubio, M., Schreier, L. E., Nakajima, K., & Berg, G. A. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.08.001 · Cited by 5

Papel de la lipotoxicidad en el desarrollo de la lesión renal en el síndrome metabólico y el envejecimiento

Izquierdo, A., & Medina‐Gómez, G. (2012) · Diálisis y Trasplante · doi:10.1016/j.dialis.2011.11.001 · Cited by 5

Severe hypertriglyceridemia does not protect from ischemic brain injury in gene-modified hypertriglyceridemic mice

Chen, Y., Liu, P., Qi, R., Wang, Y., Liu, C., & Wang, C. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.005 · Cited by 4

Diabetes and Dyslipidemia

Ginsberg, H. N., Khavandi, M., & Reyes‐Soffer, G. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_2 · Cited by 4

Ethnicity differences in plasma apoC-III levels between African American and Caucasian youths

Lee, J., Hong, H.-R., & Kang, H. (2011) · World Journal of Pediatrics · doi:10.1007/s12519-011-0266-8 · Cited by 4

Insulin Resistance and Dyslipidemia

Chahil, T. J., Reyes, G., & Ginsberg, H. N. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_11 · Cited by 4

The forkhead box O family in insulin action and lipid metabolism

Lee, S., Zhu, C., Yamauchi, J., Zhu, P., Feng, X., Qu, S., & Dong, H. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00013-0 · Cited by 3

Production of Apolipoprotein C-III Knockout Rabbits using Zinc Finger Nucleases

Yang, D., Zhang, J., Xu, J., Zhu, T., Fan, Y., Fan, J., & Chen, Y. E. (2013) · Journal of Visualized Experiments · doi:10.3791/50957-v · Cited by 3

Production and Metabolism of Triglyceride-Rich Lipoproteins in Both the Normal and Diabetic States

Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_6 · Cited by 3

FoxO1

Yamauchi, J., Kim, D. H., & Dong, H. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_634 · Cited by 3

Current Perspectives of Diabetic Dyslipidemia and Treatment Modalities

Akkuş, G. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673336501241001093417 · Cited by 2

Dysapolipoproteinaemia Influences the Relationship Between Very Low-Density Lipoprotein Cholesterol and Intra-Pancreatic Fat Deposition in Humans

Liu, Y., Skudder‐Hill, L., Ko, J., Shamaitijiang, X., Sequeira, I. R., & Petrov, M. S. (2025) · Nutrients · doi:10.3390/nu17233718 · Cited by 2

The Liver at the Crossroads: Orchestrating Lipoprotein Dynamics and Lipid Homeostasis

Winterfeldt, K., & Siddiqi, S. A. (2026) · Livers · doi:10.3390/livers6010006 · Cited by 2

Elevated levels of apolipoprotein C3 impair platelet function and reduce thrombosis

Schrottmaier, W. C., Kral-Pointner, J. B., Mußbacher, M., Salzmann, M., Hochreiter, B., Pirabe, A., Reiter, T., Badrnya, S., Schmid, J. A., Volf, I., et al. (2026) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2026.01.004 · Cited by 2

The Liver in Metabolic Syndrome

D’Amore, S., Palasciano, G., & Moschetta, A. (2013) · Springer eBooks · doi:10.1007/978-3-319-01008-3_3 · Cited by 2

Diabetes and Dyslipidemia

Ginsberg, H. N., Khavandi, M., & Reyes‐Soffer, G. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_2-4 · Cited by 2

Diabetes and Dislipidemia

Ginsberg, H. N., Khavandi, M., & Reyes‐Soffer, G. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_2 · Cited by 1

Stage-dependent dynamics of Apolipoprotein C3 across the spectrum of MASLD

Messer, E. K., Fischer, J., Herta, T., Boehlig, A., Matz‐Soja, M., Tuennemann-Tarr, A., Gaul, S., Laufs, U., & Berg, T. (2026) · PLoS ONE · doi:10.1371/journal.pone.0349666 · Cited by 1

Residual Risk Reduction Initiative: výzva ke snížení reziduálního vaskulárního rizika u pacientů s dyslipidemií

Fruchart, J., Sacks, F. M., Hermans, M. P., Assmann, G., Brown, W. V., Češka, R., Chapman, M. J., Dodson, P. M., Fioretto, P., Ginsberg, H. N., et al. (2010) · Cor et Vasa · doi:10.33678/cor.2010.056 · Cited by 1

Special Patient Populations: Diabetes and Metabolic Syndrome

Kurra, S., Chahil, T. J., & Ginsberg, H. N. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50041-x · Cited by 1

Ersonified diagnostic and correction dyslipidemia approach by profiling of apolipoproteins

Kachkovsky, M. A., Vvedenskaya, I. P., Vvedensky, V. Y., Supilnikov, A. A., Ponomareva, J. V., & Milyakova, M. N. (2020) · Bulletin of the Medical Institute REAVIZ (REHABILITATION DOCTOR AND HEALTH) · doi:10.20340/vmi-rvz.2020.4.11 · Cited by 1

Production and Metabolism of Triglyceride-Rich Lipoproteins: Impact of Diabetes

Pirillo, A., Norata, G. D., & Catapano, A. L. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_7 · Cited by 3

Special Patient Populations

Reyes‐Soffer, G., & Ginsberg, H. N. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00035-9 · Cited by 1

Diabetes and Dyslipidemia

Ginsberg, H. N., Khavandi, M., & Reyes‐Soffer, G. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_2-3 · Cited by 1

ApoC-III helical structure determines its ability to bind plasma lipoproteins and inhibit Lipoprotein Lipase-mediated triglyceride lipolysisPreprint

Vitali, C., Stankov, S. G., Khetarpal, S. A., Millar, J. S., Mayne, L. C., Englander, S. W., Hand, N. J., Lund‐Katz, S., Phillips, M. C., & Rader, D. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.02.183178 · Cited by 1

THE EFFECTS OF HYPOMORPHIC SIALIDASE EXPRESSION ON ATHEROSCLEROSIS

Yang, A. (2012) · MacSphere (McMaster University) · doi:10.71548/14532

Lipid and lipoprotein metabolism, hypolipidemic agents, and therapeutic goals

Reyes‐Soffer, G., & Ginsberg, H. N. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch17

Studies of Atherogenic Lipoproteins Using Mass Spectrometry-Based Lipidomics

Ståhlman, M. (2010) · Gothenburg University Publications Electronic Archive (Gothenburg University)

Apoproteins and Cell Surface Receptors Regulating Lipoprotein Metabolism in the Setting of Type 2 Diabetes

Dayspring, T. D. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_4

Cinética plasmática do colesterol livre e do colesterol esterificado e transferência in vitro de lípides para a HDL, utilizando uma nanoemulsão lipídica artificial, em indivíduos com intolerância à glicose

Bertato, M. P. (2010) · doi:10.11606/d.5.2010.tde-24062010-142720

Cinética plasmática do colesterol livre e do colesterol esterificado e transferência in vitro de lípides para a HDL, utilizando uma nanoemulsão lipídica artificial, em indivíduos com intolerância à glicose

Paulo, S. (2010)

Veränderungen im Lipoproteinstoffwechsel und dem Insulinsignalweg durch Diät- induzierte Adipositas

Zellbiologie, M., & Beisiegel†, U. (2008)

Low-Density Lipoproteins Containing Apolipoprotein C-III and the Risk of Coronary Heart Disease

Toth, P. P. (2012) · Yearbook of Endocrinology · doi:10.1016/j.yend.2012.05.024

[The high content of palmitinic fatty acid in food as a major cause of increase of concentration of cholesterol and low density lipoproteins and atheromatous plaques of arteries' intima].

Титов, В. Н. (2013) · PubMed

Diabetes and Dislipidemia

Ginsberg, H. N., Khavandi, M., & Reyes‐Soffer, G. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_2-1

Acute Regulation of Postprandial Lipemia and Chylomicron Production by Glucagon-Like Peptide-1 and Bile Acid Signaling

Farr, S. (2017) · TSpace (University of Toronto)

FoxO1

Yamauchi, J., Kim, D. H., & Dong, H. H. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_634-1

Diabetes and Dyslipidemia

Ginsberg, H. N., Khavandi, M., & Reyes‐Soffer, G. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_2-2

Apoproteins and Cell Surface Receptors Regulating Lipoprotein Metabolism in the Setting of Type 2 Diabetes

Dayspring, T. D., & Toth, P. P. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_4

Additional file 1 of APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groups

Goyal, S., Tanigawa, Y., Zhang, W., Chai, J.-F., Almeida, M., Sim, X., Lerner, M., Chainakul, J., Ramiu, J. G., Seraphin, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16655697

Very low-density lipoprotein and the human health

Bharadwaj, A., Taneja, M., Dubey, S., & Saxena, A. (2026) · World Journal of Experimental Medicine · doi:10.5493/wjem.v16.i1.117024

Effets des différentes techniques de chirurgie bariatrique sur le métabolisme des lipoprotéines riches en triglycérides(LRT) intestinales et hépatiques chez le patient obèse

Padilla, N. (2014) · theses.fr (ABES) · doi:10.70675/d0d25e1ez35f7z44f5z8ed8z8283dae28540

Hypertriglycéridémie postprandiale : signature microARN et insulino-résistance

housseini, R. E. (2019) · theses.fr (ABES) · doi:10.70675/7d24ea93z83a6z478aza78dzaa7adafeb958

Lipoprotéines de haute densité (HDL). Implications diagnostiques et thérapeutiques au cours de la COVID 19.

Bègue, F. (2024) · theses.fr (ABES) · doi:10.70675/520b1edazfe73z4ab2z8e24z2a42f7f5cb45

Lipoprotein (VLDL) Apolipoprotein C-III Is Strongly Related to the Concentration and Level of Production of VLDL Triglyceride in Male Subjects with Different Body Weights and Levels of Insulin Sensitivity

Cohn, J. S., Patterson, B. W., Uffelman, K. D., Davignon, J., & Steiner, G. (2013)

Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia

Cohn, J. S., Tremblay, M., Batal, R., Jacques, H., Rodriguez, C., Steiner, G. A., Mamer, O., & Davignon, J. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.06.011 · Cited by 62

Plasma Apolipoprotein C-III Transport in Centrally Obese Men: Associations with Very Low-Density

Lipoprotein Apolipoprotein, B., Apolipoprotein, L., Metabolism, A.-I., Chan, D. C., Nguyen, M. N., Watts, G. F., Hugh, P., & Barrett, R. (2013)

Plasma Apolipoprotein C-III Transport in Centrally Obese Men: Associations with Very Low-Density Lipoprotein Apolipoprotein B and High-Density Lipoprotein Apolipoprotein A-I Metabolism

Chan, D. C., Nguyen, M. N., Watts, G. F., & Barrett, P. H. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2676 · Cited by 63

Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.

Chan, D. C., Watts, G. F., Nguyen, M. N., & Barrett, P. H. R. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000203519.25116.54 · Cited by 70